Semiconductor company Siliconway Technology raised tens of millions of CNY through the angel round of funding. The funds would be mainly used for R&D, sales and marketing, teambuilding, and other business-related aspects.
It is reported that Siliconway Technology (Chinese: 芯聚威科技) had recently completed a new round of angel financing with tens of millions of CNY, led by SOX medical strategy, which is expected to accelerate the product landing and mass production within a year and to promote further the technology research and product development in the semiconductor field.
Siliconway Technology, founded in 2021, is a Semiconductor company specializing in the high-performance signal chain integrated circuit. The main products include data converters and analog front-end chips, which can be used in medical, communications, and industrial control scenarios. In addition, the key members of the Siliconway Technology team are from well-known ICT companies and R&D teams in top universities, with more than 10 years of experience in signal chain product design. Thus, it's believed that Siliconway will carry out more cutting-edge exploration, cooperating closely with SOX medical strategy in the biomedical sensing field.
Dr. Zhou Xiong, CEO of Siliconway Technology, said that with the increasing market sizes in semiconductor sectors and strategic opportunities, Siliconway Technology makes excellent contributions to the high-performance signal chain products industry, relying on the company's industry-leading technical reserves and the full support of partners.